Lisinopril: Difference between revisions
(contraindictations) |
(reactions) |
||
| Line 35: | Line 35: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
* angioedema | |||
* hypotension | |||
* hyperkalemia | |||
* renal impairment | |||
* hepatotoxicity | |||
* neutropenia | |||
*pancreatitis | |||
* steven johnson syndrome | |||
* fetal/neonatal harm | |||
* congenital malformations | |||
===Common=== | ===Common=== | ||
* dizziness | |||
* elevated Cr | |||
* headache | |||
*diarrhea | |||
* hypotension | |||
* abdominal pain | |||
* hyperkalemia | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 02:25, 1 April 2015
General
- Type: ACE inhibitor
- Dosage Forms: 2.5, 5, 10, 20, 30, 40
- Common Trade Names: Prinivil, Zestril
General information:
- Doses > 40 mg/day rarely more effective
- Decreased efficacy as mono therapy in african-american patients
- Obtain Chem 10 if starting in ED to assess renal function
Adult Dosing
- HTN: 10 - 40 mg PO Qday, max 80 mg/day
Pediatric Dosing
- 6-16 year old: 0.07 mg/kg PO qday, max 40 mg/day
Special Populations
- Pregnancy Rating: D
- Lactation: Safety unknown
- Renal Dosing
- Adult: CrCl < 30, start 2.5 mg qday, max 40 mg q/day
- Pediatric Cr Cl 30-50: decrease dose 50%, CrCl < 30, avoid use
- Hepatic Dosing
- Adult: Not defined
- Pediatric: Not defined
Contraindications
- Allergy to class/drug
- hx of angioedema
- pregnancy
- caution if renal artery stenosis
- caution if severe CHF
- caution if renal impairment
Adverse Reactions
Serious
- angioedema
- hypotension
- hyperkalemia
- renal impairment
- hepatotoxicity
- neutropenia
- pancreatitis
- steven johnson syndrome
- fetal/neonatal harm
- congenital malformations
Common
- dizziness
- elevated Cr
- headache
- diarrhea
- hypotension
- abdominal pain
- hyperkalemia
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
